Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
7–18
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Children or adolescents, aged 6 to 18 years
Diagnosis of T1D for at least 3 months
Currently managed with insulin Multiple Daily Injection (MDI) therapy
Attending full-day school schedule in Grade K through 12
Able to provide SMBG data minimum of one month prior to study start
Currently using a compatible Smartphone with ability to download the Accu-Chek® CONNECT System App accordingly OR ability to utilize Smartphone and Accu-Chek® CONNECT System App as provided for use in study
Adolescents (18 years) with diabetes provide written informed consent
Children 7 to 17 years to provide age-appropriate child assent
Parent/caregiver currently using a compatible Smartphone with ability to receive Short Message Service/Multimedia Messaging Service (SMS/MMS) messages
Able to read/write in English and comply with study procedures, including provision of self-monitoring blood glucose (SMBG) data at least 1 month prior to the study
You may not be if
Current or planned use of continuous subcutaneous insulin infusions during the study period
Use of continuous glucose monitoring or a remote data-sharing system/device (i.e. NightScout, DexCom Share, Medtronic Connect) during the study
Pregnancy
Clinically significant medical condition(s) such as anemia, major organ system disease, infection, psychosis, or cognitive impairment
Requirement for chronic steroids, immunomodulatory medication, or chemotherapy in adrenal suppressive doses
Visual impairment preventing use of the Accu-Chek® CONNECT system
Parent/caregiver is an investigator, general practitioner, practice staff, pharmacist, research assistant, or other staff or relative of those directly involved in the study
Clareo Health | Accu-Chek® CONNECT at School (CATS) Pediatric Study
